AbbVie expands Oxford R&D facility as part of £120 million-plus investment
AbbVie announced a £120 million investment to expand its Oxford R&D facility, enhancing capabilities in immunology, neuroscience, and oncology. The expansion supports new disease target research and s
reuters · 2026-11-03 16:08 UTC